PAUZA CHARLES DAVID (Chief Science Officer Virology) received a stock award from TRAWS PHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 12/16/2025ACC: 0002018150-25-000004
Officer· Chief Science Officer Virology
Since Mar 2026
+92.36K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
92.36K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+18.47K
Price / share
—
Trade value
—
% of position
18.9%
12/12/2025
97.50K→115.97K
Total
Net shares
+18.47K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/12/2025 | A · Award | +18.47K | — | — | 18.9% | 97.50K | 115.97K |
| Total | +18.47K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to purchase)
Direct
Converts to
Common Stock
73.89K shares
Shares
+73.89K
Strike price
2.33
Held after
73.89K
Exercisable
—
12/12/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to purchase) Direct | Common Stock73.89K shares | 12/12/2025 | A · Award | +73.89K | 2.33 | — | 73.89K |